Structured evidence table for Postbiotics Gut Health Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Postbiotics Gut Health Randomized Trial | However, most mechanistic data derive from rodent models; human evidence remains largely correlational and cross-sectional. | 3 | Wang R (2026) | Lachnospiraceae in the Food-Gut Axis: A Critical Review of Dietary Modulation, Immune Regulation, and Translational Barriers. |
| Postbiotics Gut Health Randomized Trial | We conclude that although Lachnospiraceae hold promise for immunomodulatory functional foods, current evidence does not support clinical or commercial claims. | 3 | Wang R (2026) | Lachnospiraceae in the Food-Gut Axis: A Critical Review of Dietary Modulation, Immune Regulation, and Translational Barriers. |
| Postbiotics Gut Health Randomized Trial | The interplay between diet, gut microbiota, and host immunity is central to food science. | 3 | Wang R (2026) | Lachnospiraceae in the Food-Gut Axis: A Critical Review of Dietary Modulation, Immune Regulation, and Translational Barriers. |
| Postbiotics Gut Health Randomized Trial | The Lachnospiraceae family ferments dietary fibers to produce short-chain fatty acids (SCFAs), notably butyrate and propionate, with immunomodulatory potential. | 3 | Wang R (2026) | Lachnospiraceae in the Food-Gut Axis: A Critical Review of Dietary Modulation, Immune Regulation, and Translational Barriers. |
| Postbiotics Gut Health Randomized Trial | The gut-immune-metabolic axis has emerged as a central regulator of human health, with growing evidence indicating that microbiota-derived metabolites improve gut microbial ecology, enhance intestinal barrier integrity, reduce systemic inflammation, and maintain metabolic homeostasis. | 4 | Abbas A (2026) | Postbiotics as Next Generation Biotherapeutics Targeting the Gut-Immune-Metabolic Axis: An Integrative Review. |
| Postbiotics Gut Health Randomized Trial | This review synthesizes current mechanistic and clinical evidence on the role of postbiotics in regulating intestinal barrier integrity, immune responses, oxidative stress, and metabolic-endocrine homeostasis. | 4 | Abbas A (2026) | Postbiotics as Next Generation Biotherapeutics Targeting the Gut-Immune-Metabolic Axis: An Integrative Review. |
| Postbiotics Gut Health Randomized Trial | The literature was identified through the PubMed/MEDLINE, Scopus, and Web of Science, integrating evidence from experimental, mechanistic, animal and clinical studies on the therapeutic potential of postbiotics to modulate the gut-immune-metabolic axis. | 4 | Abbas A (2026) | Postbiotics as Next Generation Biotherapeutics Targeting the Gut-Immune-Metabolic Axis: An Integrative Review. |
Source documents